137 related articles for article (PubMed ID: 15034302)
1. TGFbeta1, back to the future: revisiting its role as a transforming growth factor.
Glick AB
Cancer Biol Ther; 2004 Mar; 3(3):276-83. PubMed ID: 15034302
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta signaling in cancer--a double-edged sword.
Akhurst RJ; Derynck R
Trends Cell Biol; 2001 Nov; 11(11):S44-51. PubMed ID: 11684442
[TBL] [Abstract][Full Text] [Related]
3. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer.
Nilsson E; Doraiswamy V; Parrott JA; Skinner MK
Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049
[TBL] [Abstract][Full Text] [Related]
4. The transforming growth factor-beta signaling pathway in tumorigenesis.
Wieser R
Curr Opin Oncol; 2001 Jan; 13(1):70-7. PubMed ID: 11148690
[TBL] [Abstract][Full Text] [Related]
5. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
Giehl K; Seidel B; Gierschik P; Adler G; Menke A
Oncogene; 2000 Sep; 19(39):4531-41. PubMed ID: 11002426
[TBL] [Abstract][Full Text] [Related]
6. TGFbeta1 signaling via alphaVbeta6 integrin.
Kracklauer MP; Schmidt C; Sclabas GM
Mol Cancer; 2003 Aug; 2():28. PubMed ID: 12935295
[TBL] [Abstract][Full Text] [Related]
7. Activation of erbB-1 signaling in tanycytes of the median eminence stimulates transforming growth factor beta1 release via prostaglandin E2 production and induces cell plasticity.
Prevot V; Cornea A; Mungenast A; Smiley G; Ojeda SR
J Neurosci; 2003 Nov; 23(33):10622-32. PubMed ID: 14627647
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta1 stimulates urokinase plasminogen activator system on prostate cancer cells.
Unlü A; Leake RE
Int J Biol Markers; 2003; 18(2):147-51. PubMed ID: 12841684
[TBL] [Abstract][Full Text] [Related]
9. VEGFC/VEGFR3 axis mediates TGFβ1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells.
Duan L; Ye L; Zhuang L; Zou X; Liu S; Zhang Y; Zhang L; Jin C; Huang Y
PLoS One; 2018; 13(7):e0200452. PubMed ID: 29995950
[TBL] [Abstract][Full Text] [Related]
10. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
11. Divergent effect of TGFbeta1 on growth and proteolytic modulation of human prostatic-cancer cell lines.
Desruisseau S; Ghazarossian-Ragni E; Chinot O; Martin PM
Int J Cancer; 1996 Jun; 66(6):796-801. PubMed ID: 8647652
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis.
Logullo AF; Nonogaki S; Miguel RE; Kowalski LP; Nishimoto IN; Pasini FS; Federico MH; Brentani RR; Brentani MM
J Oral Pathol Med; 2003 Mar; 32(3):139-45. PubMed ID: 12581383
[TBL] [Abstract][Full Text] [Related]
13. HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment.
Cedervall J; Zhang Y; Ringvall M; Thulin A; Moustakas A; Jahnen-Dechent W; Siegbahn A; Olsson AK
Angiogenesis; 2013 Oct; 16(4):889-902. PubMed ID: 23793459
[TBL] [Abstract][Full Text] [Related]
14. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
15. Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1.
Sippel TR; Johnson AM; Li HY; Hanson D; Nguyen TT; Bullock BL; Poczobutt JM; Kwak JW; Kleczko EK; Weiser-Evans MC; Nemenoff RA
Mol Cancer Res; 2019 Aug; 17(8):1748-1758. PubMed ID: 31088909
[TBL] [Abstract][Full Text] [Related]
16. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta-1 and amphiregulin act in synergy to increase the production of urokinase-type plasminogen activator in transformed breast epithelial cells.
Giusti C; Desruisseau S; Ma L; Calvo F; Martin PM; Berthois Y
Int J Cancer; 2003 Jul; 105(6):769-78. PubMed ID: 12767061
[TBL] [Abstract][Full Text] [Related]
18. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
Bachman KE; Park BH
Curr Opin Oncol; 2005 Jan; 17(1):49-54. PubMed ID: 15608513
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta1: implications in adrenocortical tumorigenesis.
Arnaldi G; Freddi S; Mancini T; Kola B; Mantero F
Endocr Res; 2000 Nov; 26(4):905-10. PubMed ID: 11196469
[TBL] [Abstract][Full Text] [Related]
20. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
Pardali K; Moustakas A
Biochim Biophys Acta; 2007 Jan; 1775(1):21-62. PubMed ID: 16904831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
